Conference abstract · 22 Sep 2016
Review articlePublished 2017
Multi-Particulate Dosage Forms for Pediatric Use
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In recent years, regulations on pediatric medicines have induced an increased need for research into novel child appropriate dosage forms. Indeed, children cannot be considered as « small adults » as they present different anatomical and physiological characteristics. Whatever the route of administration, the age-appropriateness of the formulation is of major importance and has to be taken into consideration. The development of new pediatric dosage forms encounters technical complexities such as dose modification, ease of administration/swallowing, tastemasking, chemical and physical stability, preservation, considerations of a multi-phase and/or multi-use product, packing, providing/designing the measuring device. Innovations are important and the research of new ways to deliver medicines tends to improve compliance, convenience and pharmacokinetic. Recently, the World Human Organization recommended that small sized solid forms or orally disintegrating solid forms should be favored. Solid multi-particulate systems such as pellets have the advantage to cover a broad range of doses for different patients. Dose adjustment can be accurately done by means of dosing device such as a multi-particulate counting device. Developing multi-particulate dosage form with fast disintegration can be useful for children as they present both advantages of solid and liquid formulations. This led to the concept of Orally Disintegrating Tablet which disintegrates rapidly in the mouth into small particles or pellets. Their small size enables them to be well distributed along the gastrointestinal tract improving the bioavailability while reducing local drug concentration, risk of toxicity and side effects. They offer easy swallowing and dose flexibility for pediatric patients and caregivers. The promising results of our fast disintegrating pellets used in multi-particulate dosage forms indicate that they might be the base of a solid platform technology for pediatric medicines.
Keywords
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2020
Fabrication and Evaluation of Oral Multi-Particulate Tablets of Proton Pump Inhibitors: Esomeprazole as a Model
Research article · 11 May 2016
Design and evaluation of pH sensitive multi-particulate systems for chronotherapeutic delivery of Diltiazem hydrochloride
Research article · 30 Sep 2018
Mini-Tablet Drug Delivery System for Pediatric Dosage Form (PDF): A Review of Manufacturing Perspectives
Research article · 2014
FORMULATION AND EVALUATION OF ESOMEPRAZOLE MAGNESIUM DIHYDRATE MULTIPLE UNIT PARTICULATE SYSTEM ( PELLETS) AS A DELAYED RELEASE DOSAGE FORM
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Positive outcome in a patient with hypoplastic left heart syndrome: Key factors for successful survival: A case report
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “María Esther Martínez-Terán”
- BylineArticles whose byline prints “Thanh Huong Hoang-Thi”
- BylineArticles whose byline prints “Marie-Pierre Flament”

